## Acute Pain Management in Opioid-Tolerant Patients ### Clinical Context: Opioid Tolerance **Key Point:** This patient is opioid-tolerant (on morphine 120 mg/day). Acute pain superimposed on chronic opioid use requires careful titration with short-acting opioids to avoid both inadequate analgesia and overdose. **High-Yield:** In opioid-tolerant patients: 1. **Do NOT use standard opioid doses** (designed for opioid-naïve patients) 2. **Calculate morphine-equivalent daily dose (MEDD)** and use this to guide acute dosing 3. **Use short-acting (IV or IM) opioids** for acute pain; titrate in small increments 4. **Avoid long-acting formulations** and methadone in acute settings ### MEDD Calculation This patient's MEDD = 120 mg morphine/day. **Morphine Conversion Factors:** - Morphine ER 60 mg = Morphine IR ~20 mg every 4 hours - For acute pain in opioid-tolerant patients: use 10–15% of total daily MEDD as a single IV/IM dose **Calculation for this patient:** - 10% of 120 mg = 12 mg morphine IV - Appropriate acute dose: **10–15 mg morphine IV**, titrated to effect ### Why Morphine IR IV Is Optimal | Feature | Morphine IR IV | Fentanyl IV | Codeine IM | Methadone IV | |---------|----------------|------------|-----------|---------------| | **Onset** | 5–10 min | 3–5 min | 15–30 min | 10–20 min | | **Titration** | Easy, rapid | Easy but high potency | Weak opioid, inadequate | Unpredictable, long half-life | | **Opioid-tolerant dosing** | Straightforward (% of MEDD) | Requires conversion (1:100 morphine) | Inadequate potency | Avoided in acute settings | | **Reversibility** | Naloxone effective | Naloxone effective | Naloxone effective | Prolonged antagonism | | **Safety in tolerance** | Preferred | Acceptable if dosed correctly | Ineffective | High risk | **Clinical Pearl:** Fentanyl is 100 times more potent than morphine. In an opioid-tolerant patient on 120 mg morphine/day, a standard 100 mcg fentanyl bolus would be equivalent to only ~1.2 mg morphine — **grossly inadequate** for acute severe pain. Fentanyl is also difficult to titrate in increments small enough for safe dose escalation. ### Titration Protocol for Acute Pain in Opioid Tolerance ```mermaid flowchart TD A["Opioid-tolerant patient<br/>with acute pain"]:::outcome --> B["Calculate MEDD<br/>and 10-15% dose"]:::action B --> C["Administer morphine IR IV<br/>10-15 mg IV"]:::action C --> D{"Pain controlled?<br/>Reassess in 15 min"}:::decision D -->|"Yes, adequate"| E["Continue monitoring<br/>Repeat q15-30 min PRN"]:::action D -->|"No, inadequate"| F["Escalate by 25-50%<br/>Repeat IV dose"]:::action F --> D E --> G["Pain resolved<br/>Continue chronic regimen"]:::outcome ``` **Mnemonic:** **TRAM** — Titrate, Reassess, Adjust, Monitor (same principle as chronic opioid titration, but faster timeline) **Key Point:** Morphine IR IV allows: - Rapid onset (5–10 minutes) - Easy titration in 5–10 mg increments - Predictable pharmacokinetics - Rapid reversal with naloxone if needed ## Why Other Options Are Incorrect ### Fentanyl 100 mcg IV - **Problem:** 100 mcg fentanyl ≈ 1.2 mg morphine (using 1:100 conversion) - **Clinical error:** This is **vastly inadequate** for a patient on 120 mg morphine/day - **Risk:** Patient will remain in severe pain; may request additional doses, leading to overdose if given without understanding tolerance - **Correct fentanyl dose:** Would need 1.2–1.5 mg (12–15 mcg), which is impractical to draw up and titrate - **Lesson:** Fentanyl is useful in opioid-tolerant patients **only if dosed appropriately** (usually 1–2 mcg/kg IV for acute pain); a fixed 100 mcg dose is inappropriate ### Codeine 60 mg IM - **Problem:** Codeine is a weak opioid with a ceiling effect; maximum recommended dose is 240 mg/day - **Inadequacy:** 60 mg codeine ≈ 6 mg morphine; grossly insufficient for acute severe pain in opioid-tolerant patient - **Onset:** 15–30 minutes (slower than IV morphine) - **Indication:** Mild-to-moderate pain only; this patient has acute severe pain from femur fracture ### Methadone 10 mg IV - **Problem:** Methadone has unpredictable pharmacokinetics and a very long half-life (15–60 hours) - **Danger:** Risk of accumulation with repeated dosing; "do not repeat for 24 hours" instruction is inappropriate for acute pain management - **Acute setting:** Methadone is avoided in acute pain; reserved for chronic pain management in opioid-tolerant patients - **Better choice:** Short-acting opioids (morphine, fentanyl) for acute exacerbations ## Safety Considerations in Opioid-Tolerant Patients **Warning:** Common pitfalls: 1. **Underdosing:** Using standard opioid doses in tolerant patients → inadequate analgesia 2. **Overdosing:** Giving multiple standard doses in succession → respiratory depression, overdose 3. **Mixing formulations:** Combining ER and IR without calculating total daily dose → toxicity **Clinical Pearl:** Always ask about current opioid use and calculate MEDD before prescribing acute analgesia. Opioid-tolerant patients require 2–3× higher doses than opioid-naïve patients for equivalent analgesia. ## Monitoring - Reassess pain and respiratory status every 15 minutes after IV morphine - Target respiratory rate ≥12/min (this patient is at 18/min, safe) - Have naloxone 0.4 mg IV available at bedside - Once acute pain is controlled, resume chronic morphine ER regimen (do not discontinue)
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.